Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T15:51:50.046Z.
Calculation as of: 2026-10-06T15:51:50.046Z.
Quote observation: 2026-10-06T15:50:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 60c60f9730168f961ae5802b8b984853ffa10d75cec87ff2fe3ca57d1f3eaeef
PEG RATIO
N/A
PEG RATIO AVG TTM
N/A
PEG RATIO AVG 3Y
N/A
PEG RATIO AVG 5Y
N/A
PEG RATIO AVG 10Y
N/A
PEG RATIO AVG 15Y
N/A
PEG RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$4.45B
PEG Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indivior Pharmaceuticals Inc (INDV) | $4.44B | N/A | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | N/A | N/A | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.38B | N/A | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.33B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | N/A | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | N/A | 0.20 | 0.17 | 0.17 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | N/A | N/A | N/A | N/A |
| LivaNova PLC (LIVN)vs › | $4.16B | N/A | 1.95 | 1.95 | 1.95 |
| AbCellera Biologics Inc. (ABCL)vs › | $4.15B | N/A | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.74B | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
12.8
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2022-12-30 | 0.45 |
| 2022-12-29 | 0.45 |
| 2022-12-28 | 0.46 |
| 2022-12-27 | 0.46 |
| 2022-12-23 | 0.46 |
| 2022-12-22 | 0.46 |
| 2022-12-21 | 0.46 |
| 2022-12-20 | 0.46 |
| 2022-12-19 | 0.46 |
| 2022-12-16 | 0.46 |
| 2022-12-15 | 0.46 |
| 2022-12-14 | 0.46 |
| 2022-12-13 | 0.46 |
| 2022-12-12 | 0.44 |
| 2022-12-09 | 0.44 |
| 2022-12-08 | 0.44 |
| 2022-12-07 | 0.44 |
| 2022-12-06 | 0.44 |
| 2022-12-05 | 0.44 |
| 2022-12-02 | 0.44 |
| 2022-12-01 | 0.44 |
| 2022-11-30 | 0.44 |
| 2022-11-29 | 0.44 |
| 2022-11-28 | 0.44 |
| 2022-11-25 | 0.07 |
| 2022-11-23 | 0.07 |
| 2022-11-22 | 0.41 |
| 2022-11-21 | 0.41 |
| 2022-11-18 | 0.41 |
| 2022-11-17 | 0.41 |
| 2022-11-16 | 0.41 |
| 2022-11-15 | 0.41 |
| 2022-11-14 | 0.41 |
| 2022-11-11 | 0.41 |
| 2022-11-10 | 0.41 |
| 2022-11-09 | 0.41 |
| 2022-11-08 | 0.41 |
| 2022-11-07 | 0.41 |
| 2022-11-04 | 0.41 |
| 2022-11-03 | 0.41 |
| 2022-11-02 | 0.41 |
| 2022-11-01 | 0.41 |
| 2022-10-31 | 0.41 |
| 2022-10-28 | 0.41 |
| 2022-10-27 | 0.35 |
| 2022-10-26 | 0.35 |
| 2022-10-25 | 0.35 |
| 2022-10-24 | 0.35 |
| 2022-10-21 | 0.35 |
| 2022-10-20 | 0.35 |
| 2022-10-19 | 0.36 |
| 2022-10-18 | 0.36 |
| 2022-10-17 | 0.36 |
| 2022-10-14 | 0.33 |
| 2022-10-13 | 0.33 |
| 2022-10-12 | 0.33 |
| 2022-10-11 | 0.33 |
| 2022-10-10 | 0.33 |
| 2022-10-07 | 0.33 |
| 2022-10-06 | 0.33 |
| 2022-10-05 | 0.33 |
| 2022-10-04 | 0.33 |
| 2022-10-03 | 0.31 |
